-
Survivor Profile
In Support and ServiceRetired Army colonel and prostate cancer survivor Jim Williams asks men to pay better attention to their health.
by Lauren Gravitz
-
-
From the Editor-in-Chief
Can Big Data Launch Cancer Research?Analysis of big data in cancer medicine will be key to delivering on the cancer moonshot.
by William G. Nelson, MD, PhD
-
Forward Look
Cancer Centers Unite to Increase HPV Vaccination RatesJoint statement recommends girls and boys be vaccinated before age 13.
by Cameron Walker
-
Biden Calls for CollaborationVice president cites immunotherapy, big data and team science as innovative ways to speed progress against cancer.
by Kevin McLaughlin
-
From the Editor-in-Chief
Cancer Research: Back to the BasicsMore basic research is needed to understand how various alterations in genes lead to cancers.
by William G. Nelson, MD, PhD
-
Editor's Letter
Shoot for the MoonHow can Vice President Joe Biden's "Moonshot" initiative make true progress against cancer?
by Kevin McLaughlin
-
Survivor Profile
Living in the Here and NowA metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
-
Get Involved
The Gift of a GetawayGive patients and their families a break from cancer.
by Maria Wolf
-
Editor's Letter
Making Progress in Treating CancerCancer Today's Winter 2015/2016 issue describes advances in lung cancer, big data and more.
by Kevin McLaughlin
Alfred Lacks Carter Jr. and other family members honor the legacy of Henrietta Lacks by helping others better understand their health care.
by Kevin McLaughlin
Researchers Tackle Immune-related Adverse EffectsScientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
